EDITORIAL
Published on 05 Dec 2018
Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
doi 10.3389/fimmu.2018.02878
- 3,487 views
- 6 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immune Checkpoint Molecules and Cancer Immunotherapy
Immune Checkpoint Molecules and Cancer Immunotherapy
44k
Total downloads
170k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 27 Sep 2018
Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling
doi 10.3389/fimmu.2018.02129
- 10,107 views
- 85 citations
ORIGINAL RESEARCH
Published on 30 Aug 2018
PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma
doi 10.3389/fimmu.2018.01955
- 7,954 views
- 26 citations
REVIEW
Published on 15 Aug 2018
Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
doi 10.3389/fimmu.2018.01878
- 16,023 views
- 134 citations
MINI REVIEW
Published on 07 Aug 2018
Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer
doi 10.3389/fimmu.2018.01816
- 5,153 views
- 38 citations
ORIGINAL RESEARCH
Published on 03 Aug 2018
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
doi 10.3389/fimmu.2018.01613
- 8,908 views
- 99 citations
MINI REVIEW
Published on 31 Jul 2018
Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma
doi 10.3389/fimmu.2018.01786
- 3,778 views
- 28 citations
CASE REPORT
Published on 30 Jul 2018
Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report
doi 10.3389/fimmu.2018.01769
- 6,528 views
- 17 citations
REVIEW
Published on 27 Jul 2018
Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
doi 10.3389/fimmu.2018.01739
- 17,110 views
- 184 citations
ORIGINAL RESEARCH
Published on 19 Jul 2018
Checkpoint Blockade Rescues the Repressive Effect of Histone Deacetylases Inhibitors on γδ T Cell Function
doi 10.3389/fimmu.2018.01615
- 3,830 views
- 18 citations
ORIGINAL RESEARCH
Published on 11 Jul 2018
Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
doi 10.3389/fimmu.2018.01598
- 4,087 views
- 32 citations
REVIEW
Published on 28 Jun 2018
Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
doi 10.3389/fimmu.2018.01474
- 16,758 views
- 184 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 170kTopic views
- 119kArticle views
- 44kArticle downloads